ClinicalTrials.govpublic full text
One-Year Trial Of Oral Ziprasidone In Patients With Metabolic Syndrome
schizophrenia and disorders with psychotic features, ziprasidone, metabolic syndrome, risk factors, schizophrenia, psychotic disorders., interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 805843
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.